DAS181-3-01: A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS 181 for the Treatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects

Project: Research project

Project Details

StatusActive
Effective start/end date6/20/19 → 8/31/50

Funding

  • Ansun Biopharma, Inc.